OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation-Reference-Cited by-同舟云学术

OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation

Published:2015-03-16 Issue:1 Volume:96 Page:27-35
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Holtick Udo¹²,Chemnitz Jens-Markus¹,Shimabukuro-Vornhagen Alexander¹²,Theurich Sebastian¹²,Chakupurakal Geothy¹²,Krause Anke¹,Fiedler Anne²,Luznik Leo³,Hellmich Martin⁴,Wolf Dominik⁵,Hallek Michael¹,von Bergwelt-Baildon Michael¹²,Scheid Christof¹

Affiliation:

1. Stem Cell Transplantation Program; Department I of Internal Medicine; Center for Integrated Oncology CIO KölnBonn; University Hospital of Cologne; Cologne Germany

2. Cologne Interventional Immunology; Department I of Internal Medicine; University Hospital of Cologne; Cologne Germany

3. Sidney Kimmel Comprehensive Cancer Center and Department of Oncology; Johns Hopkins University School of Medicine; Baltimore MD USA

4. Institute of Medical Statistics, Informatics and Epidemiology; University of Cologne; Cologne Germany

5. Medical Clinic III for Oncology, Haematology and Rheumatology; Center for Integrated Oncology CIO KölnBonn; University Hospital Bonn; Bonn Germany

Funder

Bundesministerium für Bildung und Forschung

Clinical Trials Center Cologne

Forschungspool Klinische Studien', Faculty of Medicine, University of Cologne

ZKS Köln

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12541/fullpdf

Reference43 articles.

1. Graft-versus-host disease;Ferrara;Lancet,2009

2. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb;N Engl J Med,1986

3. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000

4. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation;Ratanatharathorn;Blood,1998

5. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation;Bolwell;Bone Marrow Transplant,2004

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients;Toxicology and Applied Pharmacology;2024-10

2. Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation;Phytomedicine;2024-09

3. Post-Transplant-Cyclophosphamide and short-term Everolimus as Graft-versus-Host-Prophylaxis in a real –world cohort of patients with refractory T- and B-cell Lymphoma;2024-08-17

4. Optimizing Outcomes in Mismatched Unrelated Donor Allogeneic Transplantation: Post-Transplant Cyclophosphamide’s Dual Impact on Graft versus Host Disease Incidence and Overall Survival: Retrospective Analysis on Behalf of Polish Adult Leukemia Group;Journal of Clinical Medicine;2024-06-18

5. Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET‐EVER trial;European Journal of Haematology;2024-04-14